ARAGON PHARMACEUTICALS, INC. et al v. EUGIA PHARMA SPECIALITIES LIMITED et al
ARAGON PHARMACEUTICALS, INC., JANSSEN BIOTECH, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA and SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH |
EUGIA PHARMA SPECIALITIES LIMITED, AUROBINDO PHARMA USA, INC., AUROMEDICS PHARMA LLC and EUGIA PHARMA SPECIALTIES LIMITED |
2:2022cv03186 |
May 26, 2022 |
US District Court for the District of New Jersey |
Evelyn Padin |
Leda D Wettre |
Patent - Abbreviated New Drug Application(ANDA) |
15 U.S.C. § 1126 Patent Infringement |
None |
Docket Report
This docket was last retrieved on August 9, 2023. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 19 TEXT ORDER - A telephone conference is set for August 22, 2022 at 4:00 p.m. before Magistrate Judge Leda D. Wettre for the purpose of making disclosures. Dial-in information for the conference is (888) 684-8852, access code 8948139. Plaintiffs' counsel shall advise counsel for defendant Hetero of the time, date, and dial-in information for the conference. So Ordered by Magistrate Judge Leda D. Wettre on 7/15/2022. (rn) |
Clerk`s Text Order - The document #18 Application for Clerk's Order to Ext Answer/Proposed Order submitted by AUROBINDO PHARMA USA, INC., AUROMEDICS PHARMA LLC, EUGIA PHARMA SPECIALITIES LIMITED has been GRANTED. The answer due date has been set for 8/22/2022. (lag, ) |
Filing 18 Application and Proposed Order for Clerk's Order to extend time to answer. (WALIA, GURPREET) |
Filing 17 TEXT ORDER: This matter was recently reassigned to Judge Padin. Within 14 days, the parties shall confer and file a concise joint letter: (1) providing a brief summary of the claims and defenses; and (2) advising the Court of the status of discovery, any pending motions, settlement discussions (including whether the parties are interested in a settlement conference), and any other issues to be addressed. So Ordered by Judge Evelyn Padin on 7/11/2022. (adc) |
Filing 16 NOTICE of Appearance by GURPREET SINGH WALIA on behalf of All Defendants (WALIA, GURPREET) |
Filing 15 TEXT ORDER REASSIGNING CASE. Case reassigned to Judge Evelyn Padin for all further proceedings. Judge Julien Xavier Neals no longer assigned to case. So Ordered by Chief Judge Freda L. Wolfson on 6/30/2022. (adc, ) |
Filing 14 Notice of Request by Pro Hac Vice Steven D. Maslowski, Esq. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-13523686.) (MILLER, KEITH) |
Filing 13 Notice of Request by Pro Hac Vice Matthew A. Pearson, Esq. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-13523676.) (MILLER, KEITH) |
Filing 12 Notice of Request by Pro Hac Vice Jonathan J. Underwood, Esq. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-13523663.) (MILLER, KEITH) |
Filing 11 Notice of Request by Pro Hac Vice Golda Lai, Esq. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-13523653.) (MILLER, KEITH) |
Filing 10 Notice of Request by Pro Hac Vice Anthony D. Sierra, Esq. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-13523613.) (MILLER, KEITH) |
Pro Hac Vice counsel, ANTHONY D. SIERRA, GOLDA LAI, JONATHAN J. UNDERWOOD, MATTHEW A. PEARSON and STEVEN D. MASLOWSKI, has been added to receive Notices of Electronic Filing. Pursuant to L.Civ.R. 101.1, only local counsel are entitled to sign and file papers, enter appearances and receive payments on judgments, decrees or orders. (qa, ) |
Filing 9 ORDER granting the #8 Letter Application. Golda Lai, Esq., Steven D.Maslowski, Esq., Matthew A. Pearson, Esq., Anthony D. Sierra, Esq., and Jonathan J. Underwood, Esq. are admitted to practice pro hac vice before this Court pursuant to Local Civil Rule 101.1(c). Signed by Magistrate Judge Leda D. Wettre on 6/27/2022. (qa, ) |
Filing 8 Letter from Letter from Keith J. Miller, Esq. to Hon. Leda Dunn Wettre, U.S.M.J. enclosing application for the pro hac vice admissions of Golda Lai, Esq., Steven D. Maslowski, Esq., Matthew A. Pearson, Esq., Anthony D. Sierra, Esq., and Jonathan J. Underwood, Esq.. (Attachments: #1 Declaration of Keith J. Miller, Esq., #2 Declaration of Golda Lai, Esq., #3 Declaration of Steven D. Maslowski, Esq., #4 Declaration of Matthew A. Pearson, Esq., #5 Declaration of Anthony D. Sierra, Esq., #6 Declaration of Jonathan J. Underwood, Esq., #7 Text of Proposed Order)(MILLER, KEITH) |
Filing 7 WAIVER OF SERVICE Returned Executed by SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH, ARAGON PHARMACEUTICALS, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, JANSSEN BIOTECH, INC.. AUROMEDICS PHARMA LLC waiver sent on 6/9/2022, answer due 8/8/2022. (MILLER, KEITH) |
Filing 6 WAIVER OF SERVICE Returned Executed by SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH, ARAGON PHARMACEUTICALS, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, JANSSEN BIOTECH, INC.. AUROBINDO PHARMA USA, INC. waiver sent on 6/9/2022, answer due 8/8/2022. (MILLER, KEITH) |
Filing 5 WAIVER OF SERVICE Returned Executed by SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH, ARAGON PHARMACEUTICALS, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, JANSSEN BIOTECH, INC.. EUGIA PHARMA SPECIALITIES LIMITED waiver sent on 6/9/2022, answer due 8/8/2022. (MILLER, KEITH) |
Filing 4 Corporate Disclosure Statement by ARAGON PHARMACEUTICALS, INC., JANSSEN BIOTECH, INC. identifying Johnson & Johnson as Corporate Parent.. (MILLER, KEITH) |
Filing 3 AO120 Patent Form filed. (Attachments: #1 Complaint and Exhibits) (qa, ) |
Filing 2 SUMMONS ISSUED as to AUROBINDO PHARMA USA, INC., AUROMEDICS PHARMA LLC, EUGIA PHARMA SPECIALITIES LIMITED. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (qa, ) |
Judge Julien Xavier Neals and Magistrate Judge Leda D. Wettre added. (ps) |
Filing 1 COMPLAINT against AUROBINDO PHARMA USA, INC., AUROMEDICS PHARMA LLC, EUGIA PHARMA SPECIALITIES LIMITED ( Filing and Admin fee $ 402 receipt number ANJDC-13441565) , Related Case Selected, filed by SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH, ARAGON PHARMACEUTICALS, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, JANSSEN BIOTECH, INC.. (Attachments: #1 Exhibit A to Complaint, #2 Exhibit B to Complaint, #3 Exhibit C to Complaint, #4 Exhibit D to Complaint, #5 Exhibit E to Complaint, #6 Civil Cover Sheet)(MILLER, KEITH) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.